Eftilagimod Alpha Plus Pembrolizumab in First-Line Metastatic Non–Small Cell Lung Cancer: Results From a PD-L1–Unselected Population in the TACTI-002 Study Patients with stage IB to IIB MF received ...
SANFORD, Fla. — For many years, Richard Sweat’s company, .decimal, has been producing customized medical devices for cancer treatment. Now, the company is testing what could be its most transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results